Background: Patients with peripheral arterial disease (PAD) are at increased risk of
cardiovascular morbidity and mortality. Medical prevention with antithrombotic and statin …

Objective Peripheral artery disease (PAD) is common worldwide, and PAD patients are
increasingly offered lower limb revascularization procedures. The aim of this population …

Background Patients with peripheral artery disease (PAD) treated with lower extremity
revascularization are at increased risk of major atherothrombotic vascular events (acute limb …

Objectives To assess time trends in symptomatic peripheral artery disease (PAD) incidence
and prevalence, and secondary preventive therapy. Design Cohort study using The Health …

Aims: Data on long-term healthcare costs of patients with peripheral artery disease (PAD) is
limited, and the aim of this study was to investigate healthcare costs for PAD patients at a …

Importance Patients with peripheral arterial disease (PAD) are at a high risk for
cardiovascular events, yet, to our knowledge, no studies have examined the effect of a …

Objective Long-term progression of peripheral arterial disease (PAD) as initial manifestation
of atherosclerotic arterial disease is not well described. Cardiovascular (CV) risk was …

Background Cardiovascular disease guidelines recommend that patients with established
peripheral artery disease (PAD) are prescribed antihypertensive, lipid‐lowering, and …

Background: Symptoms, severity, and acuteness of peripheral artery disease (PAD) are
major determinants of severe limb symptoms, subsequent risk of cardiovascular events, and …

Background The aim of this study was to estimate separate risks of major lower limb
amputation and death following revascularization for peripheral artery disease (PAD) using …